Table 9.
Odds ratios (ORs) and 95% confidence intervals (Cis) for relative changes of SUA (2011–2015) associated with the incidence of T2DM in 2015.
| N = 2,579 | Model 1 OR (95% CI) | Wald, df | p | Model 2 OR (95% CI) | Wald, df | p | Model 3 OR (95% CI) | Wald, df | p | Model 4 OR (95% CI) | Wald, df | p |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Male (N = 2,478) | ||||||||||||
| Q1 (619) | Ref (1.000) | Ref (1.000) | Ref (1.000) | Ref (1.000) | ||||||||
| Q2 (620) | 0.923 (0.653,1.306) | 0.2041 | 0.651 | 0.928 (0.656,1.313) | 0.1801 | 0.671 | 0.935 (0.660,1.324) | 0.1451 | 0.704 | 0.918 (0.647,1.303) | 0.2291 | 0.632 |
| Q3 (620) | 1.075 (0.767,1.505) | 0.1751 | 0.676 | 1.088 (0.776,1.524) | 0.2391 | 0.625 | 1.091 (0.778,1.530) | 0.2561 | 0.613 | 1.081 (0.770,1.518) | 0.2021 | 0.653 |
| Q4 (619) | 1.250 (0.900,1.736) | 1.7761 | 0.183 | 1.271 (0.914,1.766) | 2.0341 | 0.154 | 1.312 (0.942,1.827) | 2.5841 | 0.108 | 1.282 (0.919,1.788) | 2.1341 | 0.144 |
| P-trend | 1.088 (0.979,1.210) | 2.4381 | 0.118 | 1.094 (0.984,1.217) | 2.7551 | 0.097 | 1.104 (0.992,1.229) | 3.3091 | 0.069 | 1.097 (0.986,1.222) | 2.8791 | 0.090 |
| Female (N = 3,001) | ||||||||||||
| Q1 (749) | Ref (1.000) | Ref (1.000) | Ref (1.000) | Ref (1.000) | ||||||||
| Q2 (752) | 0.946 (0.690,1.295) | 0.1221 | 0.727 | 0.960 (0.699,1.317) | 0.0641 | 0.800 | 0.964 (0.702,1.325) | 0.0501 | 0.823 | 0.949 (0.688,1.307) | 0.1041 | 0.747 |
| Q3 (750) | 0.911 (0.664,1.251) | 0.3311 | 0.565 | 0.940 (0.683,1.292) | 0.1471 | 0.702 | 0.938 (0.681,1.291) | 0.1551 | 0.693 | 0.936 (0.678,1.293) | 0.1611 | 0.688 |
| Q4 (750) | 1.409 (1.050,1.890) | 5.2201 | 0.022 | 1.433 (1.067,1.926) | 5.7011 | 0.017 | 1.420 (1.056,1.910) | 5.3831 | 0.020 | 1.316 (0.974,1.776) | 3.2071 | 0.073 |
| P-trend | 1.115 (1.012,1.228) | 4.8581 | 0.028 | 1.122 (1.018,1.236) | 5.4101 | 0.020 | 1.118 (1.014,1.232) | 5.0351 | 0.025 | 1.092 (0.991,1.205) | 3.1301 | 0.077 |
| Total (N = 5,479) | ||||||||||||
| Q1 (1371) | Ref (1.000) | Ref (1.000) | Ref (1.000) | Ref (1.000) | ||||||||
| Q2 (1375) | 0.950 (0.753,1.199) | 0.1851 | 0.667 | 0.964 (0.763,1.218) | 0.0951 | 0.758 | 0.964 (0.763,1.218) | 0.0951 | 0.758 | 0.948 (0.749,1.200) | 0.1971 | 0.657 |
| Q3 (1365) | 0.959 (0.760,1.210) | 0.1271 | 0.722 | 0.979 (0.775,1.236) | 0.0321 | 0.857 | 0.979 (0.775,1.236) | 0.0321 | 0.857 | 0.975 (0.771,1.234) | 0.0441 | 0.835 |
| Q4 (1368) | 1.383 (1.112,1.720) | 8.4711 | 0.004 | 1.405 (1.129,1.749) | 9.6821 | 0.002 | 1.417 (1.138,1.765) | 9.6821 | 0.002 | 1.346 (1.079,1.680) | 6.9201 | 0.009 |
| p-trend | 1.111 (1.035,1.194) | 8.3931 | 0.004 | 1.118 (1.041,1.201) | 9.3371 | 0.002 | 1.120 (1.042,1.203) | 9.5641 | 0.002 | 1.103 (1.026,1.186) | 7.1021 | 0.008 |
ORs, odds ratios; CIs, confidence intervals; SUA, serum uric acid; T2DM, type 2 diabetes mellitus; BMI, body mass index.
Model 1: unadjusted.
Model 2: adjusted for age, sex (total subgroup), education level, marital status, and current residence.
Model 3: adjusted for age, sex (total subgroup), education level, marital status, current residence, smoking status, alcohol consumption, social interaction, physical activity, and chronic disease.
Model 4: adjusted for age, sex (total subgroup), education level, marital status, current residence, smoking status, alcohol consumption, social interaction, physical activity, chronic disease, and BMI.
The cutoff values of relative changes of SUA in males: <−0.089 mg/dL, −0.089 to < 0.537 mg/dL, 0.537 to < 1.238 mg/dL, ≥1.238 mg/dL.
The cutoff values of relative changes of SUA in females: <−0.058 mg/dL, −0.058 to < 0.455 mg/dL, 0.455 to < 1.005 mg/dL, ≥1.005 mg/dL.
The cutoff values of relative changes of SUA in total participants: <−0.066 mg/dL, −0.066 to < 0.487 mg/dL, 0.487 to < 1.094 mg/dL, ≥1.094 mg/dL.